A. Ro

发表

Early detection of myocardial ischemia by a novel blood-based biomarker: The kinetics of ischemia modified albumin

W. Herzog, R. Christenson, Christian D. Bounds, 2003 .

A prospective multi-site registry of real-world experience of catheter ablation for treatment of symptomatic paroxysmal and persistent atrial fibrillation (Real-AF): design and objectives

Edwin T. Zishiri, W. Fisher, A. Costea, 2021, Journal of Interventional Cardiac Electrophysiology.

Procedural time reduction associated with active esophageal cooling during pulmonary vein isolation

J. Nazari, M. Metzl, A. Ro, 2021, Journal of Interventional Cardiac Electrophysiology.

Multicenter analysis of atrioesophageal fistula rates before and after adoption of active esophageal cooling during atrial fibrillation ablation

J. Zagrodzky, K. Tamirisa, E. Kulstad, 2023, medRxiv.

Evolution of Cardiac Markers in Clinical Trials

C. Defilippi, A. Ro, 2003 .

Esophageal cooling during ablation of persistent atrial fibrillation is associated with improved freedom from arrhythmia at one-year follow up

J. Zagrodzky, S. Bailey, J. Nazari, 2022, European Heart Journal.

Arrhythmia recurrence reduction with an active esophageal cooling device during radiofrequency ablation

J. Zagrodzky, S. Bailey, A. Ruppert, 2022, EP Europace.

34 – Transseptal Catheterization

W. Fisher, A. Ro, 2011 .

Atrioesophageal Fistula Rates Before and After Adoption of Active Esophageal Cooling During Atrial Fibrillation Ablation.

S. Mickelsen, Javier E. Sanchez, J. Zagrodzky, 2023, JACC. Clinical electrophysiology.

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling.

M. Metzl, A. Ro, J. Sherman, 2024, Journal of Visualized Experiments.